Aiforia Technologies, Stratipath Enter Cancer Platform Partnership Deal

04:36 AM EDT, 08/25/2026 (MT Newswires) -- Aiforia Technologies (AIFORIA.HE) will collaborate with breast cancer diagnostics company Stratipath to streamline workflows and expand artificial intelligence-driven oncology diagnostics. The medical software company said Tuesday the partnership will see the incorporation of Stratipath's AI-based breast cancer risk profiling technology into Aiforia's breast cancer suite, as well as possible joint market projects.